{
    "Allocation": "Randomized",
    "CompleteTime": 36,
    "DesignModel": "Crossover Assignment",
    "DrugInformation": {
        "ArmGroupList": [
            {
                "ArmGroupDescription": "eplerenone 50mg/day (cross over design): 50 mg/day 6-month period , period without eplerenone (cross over design): 50 mg/day 6-month period , ",
                "ArmGroupLabel": "Eplerenone group A (cross over design)",
                "ArmGroupType": "Experimental",
                "InterventionDescription": [
                    {
                        "Dosage": "50 mg/day",
                        "DrugName": "eplerenone 50mg/day (cross over design)",
                        "Duration": "6-month period",
                        "HowToTake": ""
                    },
                    {
                        "Dosage": "50 mg/day",
                        "DrugName": "period without eplerenone (cross over design)",
                        "Duration": "6-month period",
                        "HowToTake": ""
                    }
                ],
                "InterventionList": {
                    "ArmGroupInterventionName": [
                        "Drug: Eplerenone 50mg/day (cross over design)",
                        "Other: Period without eplerenone (cross over design)"
                    ]
                }
            },
            {
                "ArmGroupDescription": "eplerenone 50mg/day (cross over design): 50 mg/day 6-month period , period without eplerenone (cross over design): 50 mg/day 6-month period , ",
                "ArmGroupLabel": "Eplerenone group B (cross over design)",
                "ArmGroupType": "Active Comparator",
                "InterventionDescription": [
                    {
                        "Dosage": "50 mg/day",
                        "DrugName": "eplerenone 50mg/day (cross over design)",
                        "Duration": "6-month period",
                        "HowToTake": ""
                    },
                    {
                        "Dosage": "50 mg/day",
                        "DrugName": "period without eplerenone (cross over design)",
                        "Duration": "6-month period",
                        "HowToTake": ""
                    }
                ],
                "InterventionList": {
                    "ArmGroupInterventionName": [
                        "Drug: Eplerenone 50mg/day (cross over design)",
                        "Other: Period without eplerenone (cross over design)"
                    ]
                }
            }
        ]
    },
    "Enrollment": "36",
    "InterventionName": "eplerenone, Period without eplerenone (cross over design)",
    "Masking": "None (Open Label)",
    "NCTID": "NCT04450953",
    "Objective": "The Effect of Eplerenone on the Evolution of Vasculopathy in Renal Transplant Patients.",
    "OfficialTitle": "A Randomized Crossover Clinical Trial Regarding the Blockage of the Mineralocorticoid Receptor Using Eplerenone on the Evolution of Arterial Stiffness in Kidney Patients One Year After Transplant",
    "PopulationBox": {
        "Condition": "Kidney Transplantation for More Than One YearPatients With a Kidney Transplantation on Cyclosporine",
        "Gender": "All",
        "HealthyCondition": "No",
        "MaxAge": "",
        "MinAge": "50 Years",
        "Participant": "36"
    },
    "PopulationRatio": "",
    "Title": "The Effect of Eplerenone on the Evolution of Vasculopathy in Renal Transplant Patients.",
    "WashoutPeriod": "2-month"
}